These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34218717)

  • 1. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).
    Lewis D
    J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID.
    Lewis D
    J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Future of Automated Insulin Delivery (AID) Systems.
    Garg SK; McVean JJ
    Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
    [No Abstract]   [Full Text] [Related]  

  • 4. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying Input Behaviors That Influence Clinical Outcomes in Diabetes and Other Chronic Illnesses.
    Lewis DM
    J Diabetes Sci Technol; 2022 May; 16(3):786-787. PubMed ID: 34971322
    [No Abstract]   [Full Text] [Related]  

  • 6. Current Status and Emerging Options for Automated Insulin Delivery Systems.
    Forlenza GP; Lal RA
    Diabetes Technol Ther; 2022 May; 24(5):362-371. PubMed ID: 35099302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption.
    Aaron RE; Tian T; Yeung AM; Huang J; Arreaza-Rubín GA; Ginsberg BH; Kompala T; Lee WA; Kerr D; Colmegna P; Mendez CE; Muchmore DB; Wallia A; Klonoff DC
    J Diabetes Sci Technol; 2024 Jan; 18(1):215-239. PubMed ID: 37811866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Errors of commission or omission: The net risk safety analysis conversation we should be having around automated insulin delivery systems.
    Lewis DM
    Diabet Med; 2022 May; 39(5):e14687. PubMed ID: 34510544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Insulin Dosing Systems or Automated Insulin Delivery Systems? It is Time for Consistency.
    Klonoff DC; Shang T; Zhang J
    J Diabetes Sci Technol; 2021 Mar; 15(2):211-213. PubMed ID: 33650456
    [No Abstract]   [Full Text] [Related]  

  • 11. Do-It-Yourself (DIY) Artificial Pancreas Systems for Type 1 Diabetes: Perspectives of Two Adult Users, Parent of a User and Healthcare Professionals.
    Ahmed SH; Ewins DL; Bridges J; Timmis A; Payne N; Mooney C; MacGregor C
    Adv Ther; 2020 Sep; 37(9):3929-3941. PubMed ID: 32696329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human-in-the-Loop Insulin Dosing.
    Bequette BW
    J Diabetes Sci Technol; 2021 May; 15(3):699-704. PubMed ID: 31801361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
    Zhou K; Isaacs D
    Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.
    Armiger R; Reddy M; Oliver NS; Georgiou P; Herrero P
    J Diabetes Sci Technol; 2022 Jan; 16(1):29-39. PubMed ID: 34861785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'We're all on the same team'. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study.
    Schipp J; Skinner TC; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabet Med; 2022 May; 39(5):e14708. PubMed ID: 34599617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 19. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated insulin dosing systems: Advances after a century of insulin.
    Thabit H; Lal R; Leelarathna L
    Diabet Med; 2021 Dec; 38(12):e14695. PubMed ID: 34547133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.